Browse studies
Find your next paid study
27 recruiting studies matching your filters
Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)
This study aims to define the natural history of men at high genetic risk for prostate cancer on the basis of specific germline genetic mutations, family histo…
Prostatic NeoplasmProstate CancerBRCA2 Mutation+5 more
Estimated
~$10 – $750
Massachusetts General HospitalNCT05129605
Phase 1
A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combi…
mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, MaleUrogenital Diseases, Male+3 more
Estimated
~$10 – $8,750
Celcuity IncNCT06190899
Double-DARE: Analysis of Doublet and Triplet Therapy With Darolutamide and Other Androgen Receptor Pathway Inhibitors in de Novo mHSPC Patients Seen in Urology Clinics in the USA
Prostate cancer is the most common non-skin cancer among men in the United States. For some men, the cancer has already spread to other parts of the body at th…
Prostatic NeoplasmsMetastatic Hormone-Sensitive Prostate Cancer
Estimated
~$10 – $1,125
BayerNCT07406282